Liver function and drug dosing: a new study for psoriasis patients
NCT ID NCT06376474
First seen Jan 05, 2026 · Last updated May 24, 2026 · Updated 15 times
Summary
This study looks at how the drug Hemay005 is processed in the body by people with mild or moderate liver problems compared to those with healthy livers. It involves 24 adults with psoriasis. The goal is to find safe and effective doses for patients with liver impairment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Union Hospital of Tongji Medical College; Huazhong University of Science and Technology
RECRUITINGWuhan, Hubei, China
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.